Stockholders' Equity - Additional Information (Detail)							3 Months Ended		9 Months Ended
	Sep. 28, 2016 USD ($) shares	Sep. 23, 2016 USD ($) $ / shares shares	Jul. 05, 2016 USD ($) shares	Jun. 07, 2016 USD ($) Tranche shares	Apr. 04, 2015 USD ($) shares	Apr. 04, 2013 USD ($) $ / shares shares	Sep. 30, 2016 USD ($) shares	Sep. 30, 2015 USD ($) shares	Sep. 30, 2016 USD ($) shares	Sep. 30, 2015 USD ($) shares	Dec. 31, 2015 shares	Jul. 22, 2015 $ / shares shares
Stockholders Equity [Line Items]
Proceeds from preferred stock issuable | $									$ 3,000,000
Preferred stock converted into common stock							5,354,574	3,718,804	5,354,574	3,718,804
Common stock, shares outstanding							13,523,544		13,523,544		13,187,544
Common stock, shares outstanding after hypothetical conversion							18,878,218		18,878,218
Fair value of preferred stock recorded as deemed dividend in statement of operations | $							$ 782,879	$ 627,705	$ 782,879	$ 627,705
Number of tranches | Tranche				2
Exchange and Redemption Agreement with Sabby Healthcare Volatility Master Fund, Ltd. [Member]
Stockholders Equity [Line Items]
Common stock, shares outstanding							13,523,544		13,523,544
Increase in common stock outstanding, percentage		39.60%
Fair value of preferred stock recorded as deemed dividend in statement of operations | $		$ 782,879
Series A Convertible Preferred Stock [Member]
Stockholders Equity [Line Items]
Series A Convertible Preferred stock, shares authorized							40,000,000		40,000,000		40,000,000
Series A Convertible Preferred stock, shares outstanding							964		964		1,041
Series A Convertible Preferred Stock [Member] | Initial Tranche [Member]
Stockholders Equity [Line Items]
Series A Convertible Preferred stock, shares authorized			200,000
Proceeds from preferred stock issuable | $			$ 1,000,000
Series A Convertible Preferred Stock [Member] | Second Tranche [Member]
Stockholders Equity [Line Items]
Series A Convertible Preferred stock, shares authorized	400,000
Proceeds from preferred stock issuable | $	$ 2,000,000
Series A Convertible Preferred Stock [Member] | Angionetics, Inc. [Member]
Stockholders Equity [Line Items]
Series A Convertible Preferred stock, shares authorized							40,000,000		40,000,000
Series A Convertible Preferred stock, shares outstanding							600,000		600,000
Preferred stock conversion basis									The Shares are initially convertible on a one to one basis into Angionetics common stock.
Percentage of stock convertible at pro rata basis				15.00%
Series A Convertible Preferred Stock [Member] | Exchange and Redemption Agreement with Sabby Healthcare Volatility Master Fund, Ltd. [Member]
Stockholders Equity [Line Items]
Effective conversion price per share | $ / shares		$ 0.18				$ 0.64						$ 0.30
Series A Convertible Preferred stock, shares outstanding		1,000					964		964			1,176
Stated value per share for redemption | $ / shares		$ 1,000
Preferred stock, redemption terms									The Exchange and Redemption Agreement granted Taxus Cardium a right to redeem any or all of the outstanding Preferred Stock for its Stated Value (approximately $1,000 per share) at any time after the date of the Agreement until November 29, 2016.
Preferred stock redemption expiry date		Nov. 29, 2016
Preferred stock converted into common stock		5,554,667					5,354,674		5,354,674
Additional preferred stock converted into common stock		2,221,867
Share Purchase Agreement [Member] | Exchange and Redemption Agreement with Sabby Healthcare Volatility Master Fund, Ltd. [Member] | Maximum [Member]
Stockholders Equity [Line Items]
Percentage of common stock issued and outstanding						10.00%
Share Purchase Agreement [Member] | Series A Convertible Preferred Stock [Member] | Angionetics, Inc. [Member]
Stockholders Equity [Line Items]
Series A Convertible Preferred stock, shares authorized				600,000
Proceeds from preferred stock issuable | $				$ 3,000,000
Share Purchase Agreement [Member] | Series A Convertible Preferred Stock [Member] | Exchange and Redemption Agreement with Sabby Healthcare Volatility Master Fund, Ltd. [Member]
Stockholders Equity [Line Items]
Series A Convertible Preferred stock, shares authorized						4,012
Proceeds from preferred stock issuable | $						$ 4,000,000
Effective conversion price per share | $ / shares						$ 0.6437
Shenzhen Qianhai Taxus [Member]
Stockholders Equity [Line Items]
Business acquisition, date of agreement									Apr. 04, 2015
Business acquisition, purchase of number of shares					600,000
Business acquisition, purchase price | $					$ 3,000,000
Payment for business acquisition | $					$ 600,000